Oui, l'âge peut affecter l'expression de Wnt-5a et son rôle dans diverses pathologies.
ÂgeExpression génétique
#3
Le tabagisme affecte-t-il Wnt-5a ?
Oui, le tabagisme peut altérer l'expression de Wnt-5a, augmentant le risque de cancer.
TabagismeRisque de cancer
#4
Y a-t-il un lien entre l'alimentation et Wnt-5a ?
Oui, une alimentation riche en graisses peut influencer négativement l'expression de Wnt-5a.
AlimentationGraisses alimentaires
#5
Le stress chronique impacte-t-il Wnt-5a ?
Oui, le stress chronique peut perturber la régulation de Wnt-5a, augmentant les risques de maladies.
Stress chroniqueRégulation hormonale
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Protéine Wnt-5a : Questions médicales les plus fréquentes",
"headline": "Protéine Wnt-5a : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Protéine Wnt-5a : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-28",
"dateModified": "2025-04-23",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Protéine Wnt-5a"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines de type Wingless",
"url": "https://questionsmedicales.fr/mesh/D051153",
"about": {
"@type": "MedicalCondition",
"name": "Protéines de type Wingless",
"code": {
"@type": "MedicalCode",
"code": "D051153",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.984"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Protéine Wnt-5a",
"alternateName": "Wnt-5a Protein",
"code": {
"@type": "MedicalCode",
"code": "D000071818",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Soon B Hwang",
"url": "https://questionsmedicales.fr/author/Soon%20B%20Hwang",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of RNA Viral Diseases, Korea Zoonosis Research Institute, Chonbuk National University, Iksan, South Korea sbhwang@jbnu.ac.kr."
}
},
{
"@type": "Person",
"name": "Rui Zhou",
"url": "https://questionsmedicales.fr/author/Rui%20Zhou",
"affiliation": {
"@type": "Organization",
"name": "Group of Cell Motility and Muscle Contraction, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China."
}
},
{
"@type": "Person",
"name": "Xiang-Dong Li",
"url": "https://questionsmedicales.fr/author/Xiang-Dong%20Li",
"affiliation": {
"@type": "Organization",
"name": "Group of Cell Motility and Muscle Contraction, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China lixd@ioz.ac.cn."
}
},
{
"@type": "Person",
"name": "Richa Mishra",
"url": "https://questionsmedicales.fr/author/Richa%20Mishra",
"affiliation": {
"@type": "Organization",
"name": "Chemical Biology Laboratory, School of Basic Sciences, Indian Institute of Technology Bhubaneswar, Bhubaneswar, Odisha, India."
}
},
{
"@type": "Person",
"name": "Soumendra Rana",
"url": "https://questionsmedicales.fr/author/Soumendra%20Rana",
"affiliation": {
"@type": "Organization",
"name": "Chemical Biology Laboratory, School of Basic Sciences, Indian Institute of Technology Bhubaneswar, Bhubaneswar, Odisha, India."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Classification of Local Recurrence After Nipple-Sparing Mastectomy Based on Location: The Features of Nipple-Areolar Recurrence Differ from Those of Other Local Recurrences.",
"datePublished": "2022-11-13",
"url": "https://questionsmedicales.fr/article/36371582",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1245/s10434-022-12760-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Feasibility of local therapy for recurrent pancreatic cancer.",
"datePublished": "2022-05-24",
"url": "https://questionsmedicales.fr/article/35641368",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.pan.2022.05.004"
}
},
{
"@type": "ScholarlyArticle",
"name": "Ultrasound Assessment of Skin Tumors Local Recurrence.",
"datePublished": "2023-05-17",
"url": "https://questionsmedicales.fr/article/37195073",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jum.16255"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pathological determinants of outcome following resection of locally advanced or locally recurrent rectal cancer.",
"datePublished": "2023-06-26",
"url": "https://questionsmedicales.fr/article/37442715",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejso.2023.06.023"
}
},
{
"@type": "ScholarlyArticle",
"name": "Intraparenchymal metastases as a cause for local recurrence of pancreatic cancer.",
"datePublished": "2022-11-21",
"url": "https://questionsmedicales.fr/article/36371607",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/his.14839"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines et peptides de signalisation intercellulaire",
"item": "https://questionsmedicales.fr/mesh/D036341"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines de type Wingless",
"item": "https://questionsmedicales.fr/mesh/D051153"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéine Wnt-5a",
"item": "https://questionsmedicales.fr/mesh/D000071818"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Protéine Wnt-5a - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Protéine Wnt-5a",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Protéine Wnt-5a",
"description": "Comment diagnostiquer une anomalie de Wnt-5a ?\nQuels tests sont utilisés pour mesurer Wnt-5a ?\nWnt-5a est-il lié à des maladies spécifiques ?\nPeut-on détecter Wnt-5a dans le sang ?\nQuels biomarqueurs sont associés à Wnt-5a ?",
"url": "https://questionsmedicales.fr/mesh/D000071818?mesh_terms=Neoplasm+Recurrence,+Local#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Protéine Wnt-5a",
"description": "Quels symptômes sont liés à une dysrégulation de Wnt-5a ?\nWnt-5a influence-t-il le cancer ?\nY a-t-il des signes cliniques de dysfonction de Wnt-5a ?\nWnt-5a affecte-t-il le système nerveux ?\nQuels effets sur la peau sont liés à Wnt-5a ?",
"url": "https://questionsmedicales.fr/mesh/D000071818?mesh_terms=Neoplasm+Recurrence,+Local#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Protéine Wnt-5a",
"description": "Peut-on prévenir les anomalies de Wnt-5a ?\nY a-t-il des facteurs environnementaux affectant Wnt-5a ?\nComment le mode de vie influence-t-il Wnt-5a ?\nLes suppléments nutritionnels aident-ils Wnt-5a ?\nLa gestion du stress influence-t-elle Wnt-5a ?",
"url": "https://questionsmedicales.fr/mesh/D000071818?mesh_terms=Neoplasm+Recurrence,+Local#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Protéine Wnt-5a",
"description": "Comment traiter les anomalies de Wnt-5a ?\nY a-t-il des médicaments ciblant Wnt-5a ?\nLa thérapie génique peut-elle aider Wnt-5a ?\nQuels traitements sont efficaces contre le cancer lié à Wnt-5a ?\nDes essais cliniques existent-ils pour Wnt-5a ?",
"url": "https://questionsmedicales.fr/mesh/D000071818?mesh_terms=Neoplasm+Recurrence,+Local#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Protéine Wnt-5a",
"description": "Quelles complications sont liées à Wnt-5a ?\nWnt-5a peut-il causer des troubles métaboliques ?\nY a-t-il des risques de récidive de cancer avec Wnt-5a ?\nWnt-5a influence-t-il la réponse immunitaire ?\nDes complications neurologiques sont-elles possibles avec Wnt-5a ?",
"url": "https://questionsmedicales.fr/mesh/D000071818?mesh_terms=Neoplasm+Recurrence,+Local#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Protéine Wnt-5a",
"description": "Quels sont les facteurs de risque pour Wnt-5a ?\nL'âge influence-t-il Wnt-5a ?\nLe tabagisme affecte-t-il Wnt-5a ?\nY a-t-il un lien entre l'alimentation et Wnt-5a ?\nLe stress chronique impacte-t-il Wnt-5a ?",
"url": "https://questionsmedicales.fr/mesh/D000071818?mesh_terms=Neoplasm+Recurrence,+Local#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une anomalie de Wnt-5a ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques et des analyses de tissus peuvent être utilisés pour évaluer les niveaux de Wnt-5a."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour mesurer Wnt-5a ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des dosages ELISA et des techniques de Western blot sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Wnt-5a est-il lié à des maladies spécifiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies de Wnt-5a sont associées à des cancers et des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Peut-on détecter Wnt-5a dans le sang ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux de Wnt-5a peuvent être mesurés dans le sérum sanguin."
}
},
{
"@type": "Question",
"name": "Quels biomarqueurs sont associés à Wnt-5a ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "D'autres protéines de la voie Wnt, comme Wnt-1 et β-caténine, peuvent être des biomarqueurs."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une dysrégulation de Wnt-5a ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies de développement, des troubles immunitaires et des cancers peuvent survenir."
}
},
{
"@type": "Question",
"name": "Wnt-5a influence-t-il le cancer ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une expression anormale de Wnt-5a est liée à la progression de certains cancers."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes cliniques de dysfonction de Wnt-5a ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des malformations congénitales et des troubles de la croissance peuvent être observés."
}
},
{
"@type": "Question",
"name": "Wnt-5a affecte-t-il le système nerveux ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, Wnt-5a joue un rôle dans le développement neuronal et peut affecter la neurogenèse."
}
},
{
"@type": "Question",
"name": "Quels effets sur la peau sont liés à Wnt-5a ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies de Wnt-5a peuvent entraîner des troubles cutanés et des cancers de la peau."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les anomalies de Wnt-5a ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par une bonne santé maternelle et des soins prénatals appropriés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs environnementaux affectant Wnt-5a ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines et à des perturbateurs endocriniens peut influencer Wnt-5a."
}
},
{
"@type": "Question",
"name": "Comment le mode de vie influence-t-il Wnt-5a ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant une alimentation équilibrée, peut soutenir la régulation de Wnt-5a."
}
},
{
"@type": "Question",
"name": "Les suppléments nutritionnels aident-ils Wnt-5a ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains suppléments, comme les acides gras oméga-3, peuvent moduler l'expression de Wnt-5a."
}
},
{
"@type": "Question",
"name": "La gestion du stress influence-t-elle Wnt-5a ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la gestion du stress peut avoir un impact positif sur la régulation de Wnt-5a."
}
},
{
"@type": "Question",
"name": "Comment traiter les anomalies de Wnt-5a ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies ciblées et des traitements immunologiques peuvent être envisagés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des médicaments ciblant Wnt-5a ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des inhibiteurs de la voie Wnt sont en développement pour traiter certains cancers."
}
},
{
"@type": "Question",
"name": "La thérapie génique peut-elle aider Wnt-5a ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est explorée pour corriger les anomalies de Wnt-5a dans certaines conditions."
}
},
{
"@type": "Question",
"name": "Quels traitements sont efficaces contre le cancer lié à Wnt-5a ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements combinés de chimiothérapie et d'immunothérapie montrent des résultats prometteurs."
}
},
{
"@type": "Question",
"name": "Des essais cliniques existent-ils pour Wnt-5a ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, plusieurs essais cliniques évaluent des traitements ciblant la voie Wnt-5a."
}
},
{
"@type": "Question",
"name": "Quelles complications sont liées à Wnt-5a ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des malformations congénitales et des cancers avancés."
}
},
{
"@type": "Question",
"name": "Wnt-5a peut-il causer des troubles métaboliques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une dysrégulation de Wnt-5a peut contribuer à des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de récidive de cancer avec Wnt-5a ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une expression anormale de Wnt-5a est associée à un risque accru de récidive."
}
},
{
"@type": "Question",
"name": "Wnt-5a influence-t-il la réponse immunitaire ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, Wnt-5a peut moduler la réponse immunitaire, affectant la susceptibilité aux infections."
}
},
{
"@type": "Question",
"name": "Des complications neurologiques sont-elles possibles avec Wnt-5a ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies de Wnt-5a peuvent entraîner des complications neurologiques."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour Wnt-5a ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des prédispositions génétiques et des expositions environnementales."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il Wnt-5a ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'âge peut affecter l'expression de Wnt-5a et son rôle dans diverses pathologies."
}
},
{
"@type": "Question",
"name": "Le tabagisme affecte-t-il Wnt-5a ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut altérer l'expression de Wnt-5a, augmentant le risque de cancer."
}
},
{
"@type": "Question",
"name": "Y a-t-il un lien entre l'alimentation et Wnt-5a ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en graisses peut influencer négativement l'expression de Wnt-5a."
}
},
{
"@type": "Question",
"name": "Le stress chronique impacte-t-il Wnt-5a ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut perturber la régulation de Wnt-5a, augmentant les risques de maladies."
}
}
]
}
]
}
Group of Cell Motility and Muscle Contraction, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
University of Chinese Academy of Sciences, Beijing 100049, China.
Group of Cell Motility and Muscle Contraction, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China lixd@ioz.ac.cn.
University of Chinese Academy of Sciences, Beijing 100049, China.
Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile; Centro de Excelencia en Biomedicina de Magallanes (CEBIMA), Escuela de Medicina, Universidad de Magallanes, Punta Arenas, Chile. Electronic address: ninestrosa@bio.puc.cl.
Group of Cell Motility and Muscle Contraction, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
Group of Cell Motility and Muscle Contraction, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
Group of Cell Motility and Muscle Contraction, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
Group of Cell Motility and Muscle Contraction, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
University of Chinese Academy of Sciences, Beijing, China.
Little information is available about the clinical and pathologic characteristics of local recurrence (LR) after nipple-sparing mastectomy according to the locations of LR....
This study classified 99 patients into the following two groups according to the location of LR after nipple-sparing mastectomy: nipple-areolar recurrence (NAR) group and other locations of LR (oLR) g...
For about half of the patients (44.4 %) with NAR, the primary cancer was estrogen receptor (ER)-negative and human epidermal growth factor receptor 2 (HER2)-positive. Conversely, in most of the patien...
This multi-institutional retrospective study demonstrated that the features of NAR, such as the characteristics of the primary and recurrent tumors and the prognostic factors after LR resection, were ...
Despite advances in perioperative management, recurrence after curative pancreatectomy is a critical issue in the treatment of pancreatic ductal adenocarcinoma (PDAC). The significance of local therap...
We reviewed the medical records of patients with PDAC who underwent curative resection at our institution between January 2009 and December 2019. We examined the patterns of relapse and assessed the c...
A total of 246 patients with PDAC who underwent R0 or R1 resection were included in this study. The 3-year overall survival (OS) rate was 39.8%, and the 1-year recurrence-free survival rate was 51.2% ...
Our results suggest that a multimodal approach may improve the clinical outcomes of patients with recurrent PDAC....
Skin cancer may recur at or around the surgical site despite wide excisions. Prompt clinical and sonographic detection of local recurrence is important since subjects with relapsing melanomas or nonme...
Pathological factors that influence and predict survival following pelvic exenteration (PE) for locally advanced (LARC) or locally recurrent rectal cancer (LRRC), especially LRRC, remain poorly unders...
A retrospective cohort study was performed for all patients undergoing a curative PE for LARC or LRRC between 2008 and 2021 at a tertiary referral UK specialist colorectal hospital. Cox regression ana...
388 patients were included in the analysis with 256 resections for LARC and 132 for LRRC. 62.4% of patients were male with a median age of 59 years (IQR 49-67). 247 (64%) partial pelvic exenterations ...
A positive resection margin and poorly differentiated tumours are significant negative prognostic markers for survival and recurrence in LARC. The results of this study support the need to look for al...
Using CODA, a technique for three-dimensional reconstruction of large tissues, Kiemen et al. report observation of a microscopic focus of pancreatic cancer found in the vasculature of grossly normal h...
The initial approach to the treatment of desmoid tumors has changed from surgical resection to watchful waiting. However, surgery is still sometimes considered for some patients, and it is likely that...
We sought to explore whether a combined molecular and clinical prognostic model for relapse in patients with desmoid tumors treated with surgery would allow us to identify patients who might do well w...
This was a retrospective, single-center study of 107 patients with desmoid tumors who were surgically treated between January 1980 and December 2015, with a median follow-up of 106 months (range 7 to ...
The multivariable analysis showed that S45F mutations (hazard ratio 5.25 [95% confidence interval 2.27 to 12.15]; p < 0.001) and tumor in the extremities (HR 3.15 [95% CI 1.35 to 7.33]; p = 0.008) wer...
CTNNB1 S45F mutations combined with other clinical variables are a potential prognostic biomarker associated with the risk of relapse in patients with desmoid tumors. The developed nomogram is simple ...
Level III, therapeutic study....
A first local recurrence is common after resection or radiotherapy for brain metastasis (BM). However, patients with BMs can develop multiple local recurrences over time. Published data on second loca...
Patients were identified from a database at Brigham and Women's Hospital in Boston. Hazard ratios and 95% confidence intervals for predictors of a second local recurrence were computed using a Cox pro...
Of 170 identified surgically treated first locally recurrent lesions, 74 (43.5%) progressed to second locally recurrent lesions at a median of 7 months after craniotomy. Subtotal resection of the firs...
A second local recurrence occurred after 43.5% of craniotomies for first recurrent lesions. Subtotal resection and infratentorial location were the strongest risk factors for worse second local recurr...
The current study was undertaken to provide more detailed prognostic models for early prediction of local recurrences and local recurrence free survival (RFS) using different radiologic and pathologic...
One hundred patients with locally advanced rectal carcinomas decided to receive neoadjuvant CRT were retrospectively recruited, Hazard ratios (HR) were determined in the two cox regression models and ...
HR of 1st group of models: T+N, T+N+G, T+N+G+S, T+N+G+S+PNI, and T+N+G+S+PNI+R were summated and categorized into scores, these scores were significantly correlated with the risk of recurrence (Somer'...
We propose that the addition of biologic factors to staging of rectal cancer provide precise stratification and association with local recurrences in patients received preoperative CRT....
This study aims to identify prognostic factors and define the best extent of surgery for optimizing treatment of local recurrence (LR) following colorectal cancer (CRC)....
An institutional database of consecutive patients who underwent radical resection (R0/R1) of LR following CRC was analyzed prospectively from 2010 to 2021 at one tertiary cancer center....
In this study, 75 patients were included with LR following CRC and analyzed. Patients were categorized as compartmental resections (CompRe) (n = 47) if all adjacent organs were systematically removed,...
Complete compartmental surgery is safe and improves local control. Optimal LR resection needs to remove all contiguous organs, with or without tumor involvement....
RET-fused mesenchymal neoplasms mostly affect the soft tissue of paediatric patients. Given their responsiveness to selective RET inhibitors, it remains critical to identify those extraordinary cases ...
Clinicopathological features were assessed and partner agnostic targeted next-generation sequencing on clinically validated platforms were performed. The patients were 18, 53, and 55 years old and inc...
Our study expands the clinicopathological and genetic spectrum of mesenchymal neoplasms associated with RET fusions....
